Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
Bristol-Myers Squibb Company
A C
A61P C07D
inventional inventional
Steven H. Aberra James R. Sören Dacia A. Wenying Toomas Jacques Y. Raj N. James Aaron Richard A. Ramesh N. Hai-Yun Ronald L. Mark E.
Spergel Fura Corte Giese Pickering Li Mitt Roberge Misra Balog Rampulla Patel Xiao Hanson Salvati